Strides Pharma Science Ltd Receives EIR from USFDA for Alathur Facility, Confirming Continued GMP Status

Strides Pharma Science Ltd, through its wholly owned subsidiary Strides A lathur Private Limited, has received an Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (USFDA) for its formulations facility at Alathur, Chennai. The successful conclusion of the Good Manufacturing Practices (GMP) inspection conducted between April 1-5, 2024 confirms the continued GMP status of the facility. The facility, which caters to the U.S. and Other Regulated Markets, manufactures tablets & capsules and supports several current and future products for the US markets. Strides Pharma Science Limited remains committed to the highest standards of compliance and manufacturing high-quality pharmaceutical products for the Global markets.